(Q35825693)

10 August 2017

Interferon-beta treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity (English)

1 reference

10 August 2017

Sten Fredrikson

7

0 references

Lars L. Gustafsson

5

object named as

Lars L Gustafsson

1 reference

10 August 2017

6

Leif Bertilsson

1 reference

10 August 2017

Karin Hellman

1

1 reference

10 August 2017

Ewa Roos

2

1 reference

10 August 2017

Anna Osterlund

3

1 reference

10 August 2017

Anneli Wahlberg

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

56

1 reference

10 August 2017

3

1 reference

10 August 2017

337-340

1 reference

Progress in determining the causes and treatment of multiple sclerosis

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884353

Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884353

Regulation of cytochromes P450 during inflammation and infection.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884353

Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884353

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884353

Potentiation of warfarin by interferon

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884353

Inhibition of antipyrine metabolism by interferon

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884353

Polymorphic hydroxylation of Debrisoquine in man.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884353

Inhibition of theophylline metabolism by interferon

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884353

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.0306-5251.2003.01859.X

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.0306-5251.2003.01859.X

Rapid high-performance liquid chromatographic method for determination of debrisoquine and 4-hydroxy-debrisoquine in urine for CYP2D6 phenotyping

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography

1 reference

12 December 2020

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

1 reference

12 December 2020

Interferon suppresses erythromycin metabolism in rats and human subjects

1 reference

12 December 2020

Interferon-alpha 2b interaction with acenocoumarol

1 reference

12 December 2020

10.1046/J.0306-5251.2003.01859.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

12919185

1 reference